Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant.
about
Pathogenesis of human immunodeficiency virus infectionEnhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positionsCounter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope.Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice.A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolatesAIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesEfficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization.Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3.Immunogen sequence: the fourth tier of AIDS vaccine design.Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo.Strategies for designing and optimizing new generation vaccines.Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins.Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease.Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines.Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.DNA vaccines against human immunodeficiency virus type 1 in the past decade.Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.Induction of anti-gp160 cytotoxic T cells cross-reacting with various V3 loop P18 peptides in human immunodeficiency virus type 1 envelope-immunized individuals.Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease.Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4(+) T Cells and Antigen Duration.New dimensions in vaccinology: A new insight.Toward computational determination of peptide-receptor structure.The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells.Duration of antigen expression in vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes.Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis.Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity.Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequenceCross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytesChimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins.
P2860
Q24634681-AC2F7ADC-4B07-4A45-B302-930105CB0C37Q30448796-B092BDFA-AC51-46A6-ADF0-B3C19B5A0EF3Q31775839-39D0AE0D-03AF-4CB5-8B05-C3A031AD93BAQ33307183-58052D94-E5CD-490B-B2C7-27A208EB5D3AQ33584559-080AEBA7-1779-4765-88C1-BFFB2D0BD0BAQ33603494-59170C24-B68C-4A2C-88FD-3055F6213965Q33604959-A068272B-9E5B-448B-B1FD-B0E016BB06BFQ33639792-E2A4E1C8-5DFA-4FB8-AD6B-826D201CE7D1Q33877287-100F1B15-489F-4F3B-B13A-8F47581D9F29Q33935668-E8C258BA-A872-4291-8094-35C4D59B4C82Q34046807-7EED951B-59C3-4AA1-ABBD-2F9A7CF60E1DQ34337482-306090E4-C7B3-4A9A-B41B-C2BD82CAF670Q34353428-45ABDDAD-B0D7-44A6-9D96-484757D1AD99Q34554756-5BE7C18E-B84B-4351-9B9A-1085C091391DQ34572198-5B832B24-7EDC-4B2F-90F7-9D309EFD2F02Q34867076-94815DF3-BB5F-4911-BA5A-1142CB0842E9Q35127401-0095D085-8604-42DE-8A30-79FEB6DA0AEBQ35182263-E3D5F520-060A-448C-AF07-D8425D9ECD18Q35634339-CB25925A-15E6-4B0F-9AC7-126C5EDC3DABQ35745831-C3D7B62D-BD29-412A-B26A-FD448A954B5CQ35781187-6F24F32E-8689-4DE1-B896-ACAA4ABAA13EQ35848078-3366E57A-5B1A-4E3F-9178-725A62D01535Q35869862-89FC814F-523F-4011-A104-5DD0A6ADEED8Q35884740-D9F71840-00E5-416D-B913-3296D6CB4EDFQ35887052-F6EFB484-20C8-4CD6-AFEB-2A239D8B9AFFQ36098933-7CAF3F0B-C643-4FD4-9F6C-5D06BD684B70Q36099003-2FFCC428-3C73-424A-8E19-98E400C56CC7Q36102001-00AEFFDC-A205-4972-B322-B083F9140158Q36265802-6F69902A-1207-4DC4-8E28-C68EE4482534Q36277738-6EAC4C6F-0AE1-4B9E-92D2-882380510105Q36315838-06800FD7-1B3A-41D2-9073-B503E7530D93Q36360453-C4DDDD96-6F82-4C21-AF6D-C0A8A27C1259Q36365966-02E37E55-D688-42A8-8811-B07FA5236202Q36454330-A1B2FFA6-593D-4368-91B4-6472E8D21FCDQ36499684-9FB28651-9FB9-41CF-A10C-410A31977DEFQ36569953-708AE26D-ED85-4EE3-9FC6-946414D135D7Q36597984-C6A13420-8045-4459-973F-A2AAB2A26897Q36648079-1E123919-5A09-4A7C-B516-D8F4EE0EC3FFQ36654435-E6EA91AC-67FA-4836-966C-310A20127091Q36655707-DADE7A94-2773-4F27-9BE3-2BDB4E550C83
P2860
Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Induction of broadly cross-rea ...... an HIV-1 envelope determinant.
@en
type
label
Induction of broadly cross-rea ...... an HIV-1 envelope determinant.
@en
prefLabel
Induction of broadly cross-rea ...... an HIV-1 envelope determinant.
@en
P2093
P356
P1433
P1476
Induction of broadly cross-rea ...... an HIV-1 envelope determinant.
@en
P2093
Berzofsky JA
Germain RN
Houghten RA
Nakagawa Y
Pendleton CD
Takahashi H
Yokomuro K
P304
P356
10.1126/SCIENCE.1372448
P407
P577
1992-01-01T00:00:00Z